Publication | Open Access
Long‐term follow‐up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with <scp>P</scp>hiladelphia chromosome–positive acute lymphoblastic leukemia
216
Citations
22
References
2015
Year
A combination of chemotherapy with dasatinib is effective in achieving long-term remission for patients with newly diagnosed Ph + ALL.
| Year | Citations | |
|---|---|---|
Page 1
Page 1